These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36773669)

  • 1. Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy.
    Mendanha D; Vieira de Castro J; Casanova MR; Gimondi S; Ferreira H; Neves NM
    Nanomedicine; 2023 Apr; 49():102663. PubMed ID: 36773669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.
    Gao C; Nie Y
    Metab Brain Dis; 2024 Apr; 39(4):569-576. PubMed ID: 38300392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
    Cui X; Morales RT; Qian W; Wang H; Gagner JP; Dolgalev I; Placantonakis D; Zagzag D; Cimmino L; Snuderl M; Lam RHW; Chen W
    Biomaterials; 2018 Apr; 161():164-178. PubMed ID: 29421553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment.
    Yang M; Wang B; Yin Y; Ma X; Tang L; Zhang Y; Fan Q; Yin T; Wang Y
    J Control Release; 2023 Jan; 353():63-76. PubMed ID: 36402232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic-Derived Docosahexaenoic Acid Liposomes for Targeting Glioblastoma and Its Inflammatory Microenvironment.
    Mendanha D; Casanova MR; Gimondi S; Ferreira H; Neves NM
    ACS Appl Mater Interfaces; 2024 Aug; 16(31):40543-40554. PubMed ID: 39042828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CEBPB
    Yang Y; Jin X; Xie Y; Ning C; Ai Y; Wei H; Xu X; Ge X; Yi T; Huang Q; Yang X; Jiang T; Wang X; Piao Y; Jin X
    Theranostics; 2024; 14(10):4107-4126. PubMed ID: 38994023
    [No Abstract]   [Full Text] [Related]  

  • 7. Silencing BMAL1 promotes M1/M2 polarization through the LDHA/lactate axis to promote GBM sensitivity to bevacizumab.
    Wang F; Liao W; Li C; Zhu L
    Int Immunopharmacol; 2024 Jun; 134():112187. PubMed ID: 38733825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.
    Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL
    Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin.
    Jang Y; Cho YS; Kim A; Zhou X; Kim Y; Wan Z; Moon JJ; Park H
    ACS Appl Mater Interfaces; 2024 Apr; 16(14):17129-17144. PubMed ID: 38533538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
    Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
    Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
    [No Abstract]   [Full Text] [Related]  

  • 13. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
    Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
    J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
    Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity.
    Balça-Silva J; do Carmo A; Tão H; Rebelo O; Barbosa M; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC; Moreira JN
    Exp Cell Res; 2018 Sep; 370(1):68-77. PubMed ID: 29902537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma.
    Cao Z; Liu X; Zhang W; Zhang K; Pan L; Zhu M; Qin H; Zou C; Wang W; Zhang C; He Y; Lin W; Zhang Y; Han D; Li M; Gu J
    ACS Nano; 2023 Dec; 17(23):23746-23760. PubMed ID: 37991252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma.
    Jiang S; Li W; Yang J; Zhang T; Zhang Y; Xu L; Hu B; Li Z; Gao H; Huang Y; Ruan S
    ACS Nano; 2024 Feb; 18(8):6445-6462. PubMed ID: 38358804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
    Ali S; Borin TF; Piranlioglu R; Ara R; Lebedyeva I; Angara K; Achyut BR; Arbab AS; Rashid MH
    PLoS One; 2021; 16(2):e0246646. PubMed ID: 33544755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
    Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
    Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Heterotypic Tridimensional Model to Study the Interaction of Macrophages and Glioblastoma In Vitro.
    Gattas MJ; Estecho IG; Lago Huvelle MA; Errasti AE; Carrera Silva EA; Simian M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.